Fractyl Health (GUTS) Common Equity (2023 - 2026)

Fractyl Health (GUTS) has reported Common Equity for 4 consecutive years, with -$1.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity rose 90.86% year-over-year to -$1.7 million; the trailing twelve-month figure through Jun 2026 stood at -$1.7 million (up 90.86% YoY), and the FY2025 full-year result was $9.5 million, down 66.73% from the prior year.
• Common Equity was -$1.7 million for Q2 2026 at Fractyl Health, down from $21.4 million in the prior quarter.
• The five-year high for Common Equity was $84.2 million in Q1 2024, with the low at -$325.1 million in Q4 2023.
• Historically, Common Equity has averaged -$67.2 million across 4 years, with a median of $2.4 million in 2025.
• Annual changes were most pronounced in 2025 — Common Equity sank 125.74% — and 2026, when it jumped 235.33%.
• Tracing GUTS's Common Equity over 4 years: stood at -$325.1 million in 2023, then surged by 108.74% to $28.4 million in 2024, then slumped by 66.73% to $9.5 million in 2025, then slumped by 117.6% to -$1.7 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were -$1.7 million in Q2 2026, $21.4 million in Q1 2026, and $9.5 million in Q4 2025.